The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

被引:106
作者
Siegmund, Soeren V.
Qian, Ting
de Minicis, Samuele
Harvey-White, Judith
Kunos, George
Vinod, K. Y.
Hungund, Basalingappa
Schwabe, Robert F.
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA
[2] Heidelberg Univ, Med Fac Mannheim, Dept Med 2, D-6800 Mannheim, Germany
[3] Univ Texas, Med Branch, Dept Cell Biol & Neurosci, Galveston, TX 77550 USA
[4] NIAAA, NIH, Bethesda, MD USA
[5] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
[6] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
关键词
ROS; 2-AG; HSC; hepatocyte; fibrosis;
D O I
10.1096/fj.06-7717com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The endocannabinoid system is an important regulator of hepatic fibrogenesis. In this study, we determined the effects of 2- arachidonoyl glycerol ( 2- AG) on hepatic stellate cells ( HSCs), the main fibrogenic cell type in the liver. Culture- activated HSCs were highly susceptible to 2- AG- induced cell death with > 50% cell death at 10 mu M after 18 h of treatment. 2- AG- induced HSC death showed typical features of apoptosis such as PARP- and caspase 3- cleavage and depended on reactive oxygen species ( ROS) formation. Confocal microscopy revealed mitochondria as primary site of ROS production and demonstrated mitochondrial depolarization and increased mitochondrial permeability after 2- AG treatment. 2- AG- induced cell death was independent of cannabinoid receptors but required the presence of membrane cholesterol. Primary hepatocytes were resistant to 2- AG- induced ROS induction and cell death but became susceptible after GSH depletion suggesting antioxidant defenses as a critical determinant of 2- AG sensitivity. Hepatic levels of 2- AG were significantly elevated in two models of experimental fibrogenesis and reached concentrations that are sufficient to induce death in HSCs. These findings suggest that 2- AG may act as an antifibrogenic mediator in the liver by inducing cell death in activated HSCs but not hepatocytes.
引用
收藏
页码:2798 / 2806
页数:9
相关论文
共 53 条
[1]   NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis [J].
Bataller, R ;
Schwabe, RF ;
Choi, YH ;
Yang, L ;
Paik, YH ;
Lindquist, J ;
Qian, T ;
Schoonhoven, R ;
Hagedorn, CH ;
Lemasters, JJ ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (09) :1383-1394
[2]   Hepatic stellate cells as a target for the treatment of liver fibrosis [J].
Bataller, R ;
Brenner, DA .
SEMINARS IN LIVER DISEASE, 2001, 21 (03) :437-451
[3]   Evidence for novel cannabinoid receptors [J].
Begg, M ;
Pacher, P ;
Bátkai, S ;
Osei-Hyiaman, D ;
Offertáler, L ;
Mo, FM ;
Liu, H ;
Kunos, G .
PHARMACOLOGY & THERAPEUTICS, 2005, 106 (02) :133-145
[4]   Cannabinoid-receptor-independent cell signalling by N-acylethanolamines [J].
Berdyshev, EV ;
Schmid, PC ;
Krebsbach, RJ ;
Hillard, CJ ;
Huang, CS ;
Chen, NY ;
Dong, ZG ;
Schmid, HHO .
BIOCHEMICAL JOURNAL, 2001, 360 (360) :67-75
[5]   Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis [J].
Biswas, KK ;
Sarker, KP ;
Abeyama, K ;
Kawahara, K ;
Iino, S ;
Otsubo, Y ;
Saigo, K ;
Izumi, H ;
Hashiguchi, T ;
Yamakuchi, M ;
Yamaji, K ;
Endo, R ;
Suzuki, K ;
Imaizumi, H ;
Maruyama, I .
HEPATOLOGY, 2003, 38 (05) :1167-1177
[6]   Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor [J].
Buckley , NE ;
McCoy, KL ;
Mezey, É ;
Bonner, T ;
Zimmer, A ;
Felder, CC ;
Glass, M ;
Zimmer, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 396 (2-3) :141-149
[7]   Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis [J].
Costantini, P ;
Belzacq, AS ;
La Vieira, H ;
Larochette, N ;
de Pablo, MA ;
Zamzami, N ;
Susin, SA ;
Brenner, C ;
Kroemer, G .
ONCOGENE, 2000, 19 (02) :307-314
[8]   NADPH oxidase in the liver: Defensive, offensive, or fibrogenic? [J].
De Minicis, Samuele ;
Bataller, Ramon ;
Brenner, David A. .
GASTROENTEROLOGY, 2006, 131 (01) :272-275
[9]   Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders [J].
De Petrocellis, L ;
Melck, D ;
Bisogno, T ;
Di Marzo, V .
CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) :191-209
[10]  
Derkinderen P, 2003, J NEUROSCI, V23, P2371